STOCK TITAN

DGX (DGX) holder files Form 144 to sell 26,165 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of DGX has filed a notice under Rule 144 to sell 26,165 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/13/2026. The filing lists an aggregate market value of these shares of 5428714.20. The shares were acquired on 02/13/2026 by exercising stock options that were originally granted on 02/18/2020, with payment in cash. The notice states that 111,242,362 shares of the issuer’s common stock were outstanding, providing context for the planned transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DGX Form 144 filing disclose?

The Form 144 discloses a plan to sell 26,165 DGX common shares under Rule 144. The shares have an aggregate market value of 5428714.20 and are planned to be sold on the NYSE through Fidelity Brokerage Services LLC.

How many DGX shares are planned for sale under Rule 144?

The filing covers a proposed sale of 26,165 DGX common shares. These shares were recently acquired through an option exercise and have an indicated aggregate market value of 5428714.20 at the time of the notice.

When were the DGX shares being sold under Form 144 acquired?

The DGX shares were acquired on 02/13/2026 by exercising stock options. Those options were originally granted on 02/18/2020, and the acquisition of 26,165 shares was paid for in cash according to the filing.

What is the reported market value of DGX shares in the Form 144?

The Form 144 reports an aggregate market value of 5428714.20 for the 26,165 DGX common shares planned for sale. This value reflects the total market worth of the block of shares covered by the notice at the referenced time.

How many DGX shares were outstanding according to the Form 144?

The notice states that 111,242,362 DGX common shares were outstanding. This number provides a baseline for understanding the relative size of the 26,165-share planned sale described in the Rule 144 filing.

On which exchange will the DGX shares in the Form 144 be sold?

The filing indicates that the 26,165 DGX common shares are planned to be sold on the NYSE. Fidelity Brokerage Services LLC is listed as the broker handling the transaction for the selling shareholder.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

22.81B
110.75M
0.4%
99.16%
3.8%
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS